This study evaluated the diagnostic performance of non-invasive tests (NITs) like the FibroScan-AST (FAST) score, LSM-VCTE, FIB-4, and NFS for screening metabolic dysfunction-associated steatohepatitis (MASH) in clinical trials.
Read More > https://mash.pocn.com/diagnosis/sequential-nit-screening-for-mash-reduces-biopsies-and-costs/
